Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation: Results From the PTRG-DES Consortium
  • Lee, S.-J.
  • Cha, J.-J.
  • Jeong, Y.-H.
  • Hong, S.-J.
  • Ahn, C.-M.
  • 외 19명
Citations

WEB OF SCIENCE

19
Citations

SCOPUS

20

초록

Background: The long-term prognostic implication of platelet reactivity after percutaneous coronary intervention (PCI) is not clearly known. Objectives: The impacts of platelet reactivity from the PTRG-DES consortium were assessed. Methods: The primary endpoint was the major adverse cardiac and cerebrovascular events (MACCE) including all-cause death, myocardial infarction, stent thrombosis, or stroke. Key secondary endpoints were all-cause mortality, major bleeding, and net adverse clinical events (NACE), including MACCE and bleeding. Results: Between 2003 and 2018, a total of 11,714 patients were enrolled and grouped into tertiles according to P2Y12 reaction units (PRUs): high PRUs (≥253), intermediate PRUs (188-252), and low PRUs (<188). The Kaplan-Meier (KM) estimates of the primary outcome were significantly different across the groups; the high-PRU group showed the highest MACCE rate at 5 years (12.9%, 11.1%, and 7.0% in high-, intermediate-, and low-PRU groups, respectively; P < 0.001), as well as at 1 year (P < 0.001). The high-PRU group had the greatest KM estimates of all-cause death (8.2%, 5.9%, and 3.7%, respectively; P < 0.001) at 5 years without significant differences of major bleeding, and resultant of a higher KM estimates of NACE (15.7%, 13.6%, and 9.7%, respectively; P < 0.001). A PRU ≥252, the best cutoff value, was strongly related to MACCE (HR: 1.39; 95% CI: 1.11-1.74; P = 0.003) and all-cause death at 5 years after PCI (HR: 1.42; 95% CI: 1.04-1.94; P = 0.026). The optimal cutoff value of aspirin reaction units predicting the MACCE occurrence was ≥414 and was significantly associated with 5-year MACCE occurrence or all-cause death (P < 0.001). Conclusions: In this large-scale cohort, high PRU was significantly associated with occurrence of MACCE, all-death death, and NACE at 5 years, as well as 1 year after PCI. (PTRG-DES Consortium [PTRG]; NCT04734028) © 2022 American College of Cardiology Foundation

키워드

drug-eluting stent(s)percutaneous coronary interventionplatelet function testsstent thrombosisPERCUTANEOUS CORONARY INTERVENTIONADJUST ANTIPLATELET THERAPYEAST-ASIAN PATIENTSRANDOMIZED-TRIALOPEN-LABELEND-POINTCLOPIDOGRELASPIRINEVENTSDEFINITIONS
제목
Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation: Results From the PTRG-DES Consortium
저자
Lee, S.-J.Cha, J.-J.Jeong, Y.-H.Hong, S.-J.Ahn, C.-M.Kim, J.-S.Ko, Y.-G.Choi, D.Hong, M.-K.Jang, Y.Joo, H.J.Chang, K.Park, Y.Song, Y.B.Ahn, S.G.Suh, J.-W.Lee, S.Y.Cho, J.R.Her, A.-Y.Kim, H.-S.Kim, M.H.Shin, E.-S.Lim, D.-S.Kim, B.-K.
DOI
10.1016/j.jcin.2022.09.007
발행일
2022-11
유형
Article
저널명
JACC: Cardiovascular Interventions
15
22
페이지
2253 ~ 2265